Bruker Corporation (BRKR)
Automate Your Wheel Strategy on BRKR
With Tiblio's Option Bot, you can configure your own wheel strategy including BRKR - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol BRKR
- Rev/Share 22.6691
- Book/Share 16.4298
- PB 2.5255
- Debt/Equity 0.82
- CurrentRatio 1.8536
- ROIC 0.004
- MktCap 6187100820.0
- FreeCF/Share -0.0699
- PFCF -583.6888
- PE -312.4407
- Debt/Assets 0.3121
- DivYield 0.0049
- ROE -0.0101
- Rating C
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 4
- P/B Score 3
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Downgrade | BRKR | Citigroup | Buy | Neutral | -- | $40 | May 22, 2025 |
| Initiation | BRKR | Guggenheim | -- | Buy | -- | $72 | Dec. 19, 2024 |
| Initiation | BRKR | UBS | -- | Neutral | -- | $66 | Dec. 10, 2024 |
| Upgrade | BRKR | Goldman | Sell | Neutral | -- | $60 | Dec. 5, 2024 |
| Initiation | BRKR | Barclays | -- | Overweight | -- | $75 | Oct. 15, 2024 |
| Downgrade | BRKR | Wolfe Research | Outperform | Peer Perform | -- | -- | Sept. 30, 2024 |
| Initiation | BRKR | Wells Fargo | -- | Overweight | -- | $78 | Aug. 28, 2024 |
News
Bruker Stock to Benefit From the Launch of X4 POSEIDON Benchtop XRM
Published: March 06, 2025 by: Zacks Investment Research
Sentiment: Positive
BRKR unveils X4 POSEIDON advanced XRM for 3D microscopy in industrial and scientific applications.
Read More
Bruker Launches X4 POSEIDON™ Advanced X-Ray Microscope for Three-Dimensional Microscopy in Industrial and Scientific Applications
Published: February 27, 2025 by: Business Wire
Sentiment: Neutral
KONTICH, Belgium--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announces the launch of the new X4 POSEIDON™, a high-performance 3D X-ray microscope (XRM) using micro-Computed Tomography (microCT). This innovative benchtop XRM system offers advanced capabilities comparable to larger, floor-standing systems to make high-resolution 3D X-ray microscopy accessible for demanding XRM applications in industrial applications and scientific research. The X4 POSEIDON features a high-end X-ray.
Read More
Bruker Corporation to Present at Upcoming Investor Conferences
Published: February 20, 2025 by: Business Wire
Sentiment: Neutral
BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) announced today that its senior leadership will present at the following conferences: Citi 2025 Unplugged Medtech and Life Sciences Access Day in New York City Thursday, February 27, 2025, at 2:30 p.m. Eastern Time TD Cowen 45th Annual Health Care Conference in Boston, MA Wednesday, March 5, 2025, at 11:10 a.m. Eastern Time Barclays 27th Annual Global Healthcare Conference in Miami, FL Tuesday, March 11, 2025, at 2:30 p.m. Eas.
Read More
Bruker Q4 Earnings & Revenues Surpass Estimates, Stock Falls
Published: February 14, 2025 by: Zacks Investment Research
Sentiment: Positive
Bruker delivers better-than-expected earnings and revenues in the fourth quarter of 2024.
Read More
Bruker Corporation (BRKR) Q4 2024 Earnings Call Transcript
Published: February 13, 2025 by: Seeking Alpha
Sentiment: Neutral
Bruker Corporation (NASDAQ:BRKR ) Q4 2024 Results Conference Call February 13, 2025 8:30 AM ET Company Participants Joe Kostka - Director, Investor Relations Frank Laukien - President and CEO Gerald Herman - Executive Vice President and CFO Conference Call Participants Puneet Souda - Leerink Partners Elizabeth Speyer - Citigroup Salem Salem - Barclays Brandon Couillard - Wells Fargo Madeline Mollman - Wolfe Research Tycho Peterson - Jefferies Subbu Nambi - Guggenheim Securities Operator Good day, and welcome to the Bruker Corporation Fourth Quarter 2024 Earnings Conference Call. [Operator Instructions] Please note this event is being recorded.
Read More
Bruker (BRKR) Reports Q4 Earnings: What Key Metrics Have to Say
Published: February 13, 2025 by: Zacks Investment Research
Sentiment: Positive
Although the revenue and EPS for Bruker (BRKR) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Read More
About Bruker Corporation (BRKR)
- IPO Date 2000-08-04
- Website https://www.bruker.com
- Industry Medical - Devices
- CEO Frank H. Laukien
- Employees 11396